Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Gains from Investment Securities (2016 - 2026)

Intellia Therapeutics has reported Gains from Investment Securities over the past 12 years, most recently at $731481.0 for Q1 2026.

  • Quarterly Gains from Investment Securities changed N/A to $731481.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $731481.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $5.2 million for FY2025, 963.21% up from the prior year.
  • Gains from Investment Securities was $731481.0 for Q1 2026 at Intellia Therapeutics, down from $5.2 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $66.9 million in Q4 2022 and troughed at -$3.0 million in Q4 2024.
  • The 5-year median for Gains from Investment Securities is $650651.0 (2023), against an average of $5.5 million.
  • Year-over-year, Gains from Investment Securities surged 357.08% in 2023 and then crashed 1658.14% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $66.9 million in 2022, then tumbled by 100.26% to -$172000.0 in 2023, then crashed by 1658.14% to -$3.0 million in 2024, then soared by 271.09% to $5.2 million in 2025, then plummeted by 85.86% to $731481.0 in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Gains from Investment Securities are $731481.0 (Q1 2026), $5.2 million (Q4 2025), and $783901.0 (Q3 2025).